Drug Profile
Hydromorphone controlled release - ALZA Corporation
Alternative Names: AP 77; Dilaudid; Dilaudid Oros; Exalgo; Hydromorphone extended release; Hydromorphone HCl; Hydromorphone hydrochloride; Jurnista; NMED-1077; OROS® HydromorphoneLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Therapeutic Discovery Corporation
- Developer ALZA Corporation; Fresenius Kabi; Johnson & Johnson; Mallinckrodt Inc.
- Class Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Cancer pain; Pain